Document type
Book partVersion
Published versionPublication date
All rights reserved
Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/67564
Inflammation and metabolic dysregulation in diabetic cardiomyopathy
Journal Title
Director/Tutor
Journal ISSN
Volume Title
Related resource
Abstract
Diabetic cardiomyopathy is characterized by structural and functional alterations in the heart muscle of people with diabetes that finally lead to heart failure. Metabolic disturbances characterized by increased lipid oxidation, intramyocardial triglyceride accumulation and reduced glucose utilization have all been involved in the pathogenesis of diabetic cardiomyopathy. On the other hand, evidences arisen in the recent years point to a potential link between chronic low-grade inflammation in the heart and metabolic dysregulation. Interestingly, the progression of heart failure and cardiac hypertrophy usually entails the activation of pro-inflammatory pathways. Therefore, in this chapter we summarize novel insights into the crosstalk between inflammatory processes and metabolic dysregulation in the failing heart during diabetes.
Description
Podeu consultar el llibre complet a: http://hdl.handle.net/2445/67430
Subject (English)
Citation
Citation
PALOMER TARRIDAS, Francesc Xavier, BARROSO FERNÁNDEZ, Emma and VÁZQUEZ CARRERA, Manuel. Inflammation and metabolic dysregulation in diabetic cardiomyopathy. Recent Advances in Pharmaceutical Sciences V. 2015. Vol. Editors: Diego Muñoz Torrero, num. Pilar Vinardell & Javier Palazón, pags. 167-186. [consulted: 11 of August of 2026]. Available at: https://hdl.handle.net/2445/67564